Literature DB >> 31381879

Down-regulation of MARCO associates with tumor progression in hepatocellular carcinoma.

Yusha Xiao1, Baiyang Chen1, Kang Yang2, Quanxiong Wang1, Pengpeng Liu1, Yang Gu1, Qiu Zhong1, Zhisu Liu1, Yueming He3, Quanyan Liu4.   

Abstract

Hepatocellular carcinoma(HCC) is a malignant tumor with high mortality due to lack of early diagnostic methods and effective treatments, and the molecular mechanisms are intricate and remain unclear. In the present study, the role of macrophage receptor with collagenous structure (MARCO) in tumor advancement of HCC was investigated. We examined expression level of MARCO in HCC samples, corresponding adjacent nontumor tissues and six hepatoma cell lines by polymerase chain reaction and immunohistochemistry (IHC). Clinical information of HCC patients was also analyzed. The role of MARCO involved in HCC progression via multiple functional experiments in vitro and in vivo was investigated. Bioinformatics analysis was conducted to further explore biological functions of MARCO. We found MARCO was suggestively down-regulated in HCC and associated with favorable prognosis, and MARCO upregulation oppressed tumor cell migration and invasion. Besides, overexpression of MARCO not only promoted apoptosis of hepatoma cells but also suppressed proliferation in vivo and in vitro. Furthermore, gene set enrichment analysis (GSEA) analysis suggested that MARCO may be related to the P53 signaling pathway, and this prediction was confirmed in this study as well. In sum, our study indicated that MARCO was involved in HCC progression and it can be defined as a novel probable biomarker as well as treatment target for HCC.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Gene expression omnibus (GEO); Hepatocellular carcinoma (HCC); MARCO; P53 signaling pathway; The cancer genome atlas (TCGA)

Year:  2019        PMID: 31381879     DOI: 10.1016/j.yexcr.2019.111542

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  3 in total

1.  Association of the MARCO polymorphism rs6761637 with hepatocellular carcinoma susceptibility and clinical characteristics.

Authors:  Zhenzhen Su; Limei Luo; Xiaojuan Wu; Bin Wei; Lu Wang; Fei Liu; Bei Cai
Journal:  Immunol Res       Date:  2022-04-01       Impact factor: 2.829

2.  Cholangiocarcinoma: what are the most valuable therapeutic targets - cancer-associated fibroblasts, immune cells, or beyond T cells?

Authors:  Juan Wang; Emilien Loeuillard; Gregory J Gores; Sumera I Ilyas
Journal:  Expert Opin Ther Targets       Date:  2021-12-03       Impact factor: 6.797

Review 3.  Scavenger Receptors: Novel Roles in the Pathogenesis of Liver Inflammation and Cancer.

Authors:  Daniel A Patten; Alex L Wilkinson; Ayla O'Keeffe; Shishir Shetty
Journal:  Semin Liver Dis       Date:  2021-09-22       Impact factor: 6.512

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.